For the quarter ending 2026-03-31, EDIT made $2,831K in revenue. -$24,982K in net income. Net profit margin of -882.44%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Collaboration and other research and development revenues | 2,831 | 24,741 | 7,543 | 3,578 |
| Research and development | 17,600 | 27,404 | 19,775 | 16,181 |
| General and administrative | 10,234 | 11,353 | 12,316 | 12,859 |
| Restructuring and impairment charges | 0 | -6,261 | 0 | 26,082 |
| Total operating expenses | 27,834 | 32,496 | 32,091 | 55,122 |
| Operating loss | -25,003 | -7,755 | -24,548 | -51,544 |
| Interest expense related to sale of future revenues | 1,072 | -464 | 2,399 | 2,020 |
| Interest income, net | 1,206 | 1,676 | 1,831 | 2,087 |
| Other expense, net | -113 | -5 | -1 | -1,758 |
| Total other income, net | 21 | 2,135 | -569 | -1,691 |
| Net loss | -24,982 | -5,620 | -25,117 | -53,235 |
| Basic EPS | -0.26 | -0.058 | -0.28 | -0.63 |
| Diluted EPS | -0.26 | -0.058 | -0.28 | -0.63 |
| Basic Average Shares | 97,879,343 | 97,425,969 | 90,090,397 | 84,412,200 |
| Diluted Average Shares | 97,879,343 | 97,425,969 | 90,090,397 | 84,412,200 |
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT)